Andrology & Gynecology: Current ResearchISSN: 2327-4360

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Androl Gynecol Curr Res Vol: 3 Issue: 1

Discovery of a New Anti Androgen Compound

Mustafa Pehlivan*
School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL 10 9AB, UK
Corresponding author : Mustafa Pehlivan
School of Life and Medical Sciences, University of Hertfordshire, College Lane, Hatfield, Hertfordshire AL 10 9AB, UK
Tel: 447758414188; E-mail: [email protected]
Received: November 17, 2014 Accepted: March 13, 2015 Published: March 20, 2015
Citation: Pehlivan M (2015) Discovery of a New Anti Androgen Compound. Androl Gynecol: Curr Res 3:1. doi:10.4172/2327-4360.1000134

Abstract

Discovery of a New Anti Androgen Compound

Androgen receptor inhibitors reduce or eliminate symptoms of prostate cancer by inhibiting Androgen receptors. The main advantage of this new compound is that it does not block any other receptors except androgen, and therefore it is very specific. Also another advantage of it in terms of its mechanism of inhibition is that its inhibition efficacy is about 90%, and therefore it would be a very efficient anti-cancer drug for prostate cancer and related diseases. Also when compared to other anti-Androgen drugs, this drug has a different and better enzalutamide activity. 

Keywords: Drug; Discovery; Development; Pharmacokinetics; Pharmacodynamics; Pharmacology; ADME; Pharmacy

Track Your Manuscript

Share This Page

Associations